Vaxart Free Cash Flow from 2010 to 2025
| VXRT Stock | USD 0.68 0.00 0.000001% |
Free Cash Flow | First Reported 1989-09-30 | Previous Quarter -12.4 M | Current Value -4.2 M | Quarterly Volatility 10.5 M |
Check Vaxart financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxart's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.1 M, Interest Expense of 1.4 M or Total Revenue of 6.3 M, as well as many indicators such as Price To Sales Ratio of 9.61, Dividend Yield of 0.0 or PTB Ratio of 2.34. Vaxart financial statements analysis is a perfect complement when working with Vaxart Valuation or Volatility modules.
Vaxart | Free Cash Flow |
Latest Vaxart's Free Cash Flow Growth Pattern
Below is the plot of the Free Cash Flow of Vaxart Inc over the last few years. It is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets. Vaxart's Free Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaxart's overall financial position and show how it may be relating to other accounts over time.
| Free Cash Flow | 10 Years Trend |
|
Free Cash Flow |
| Timeline |
Vaxart Free Cash Flow Regression Statistics
| Arithmetic Mean | (32,792,914) | |
| Coefficient Of Variation | (93.73) | |
| Mean Deviation | 25,582,131 | |
| Median | (15,167,000) | |
| Standard Deviation | 30,737,831 | |
| Sample Variance | 944.8T | |
| Range | 105.4M | |
| R-Value | (0.80) | |
| Mean Square Error | 361.7T | |
| R-Squared | 0.64 | |
| Significance | 0.0002 | |
| Slope | (5,176,018) | |
| Total Sum of Squares | 14172.2T |
Vaxart Free Cash Flow History
Other Fundumenentals of Vaxart Inc
Vaxart Free Cash Flow component correlations
About Vaxart Financial Statements
Vaxart shareholders use historical fundamental indicators, such as Free Cash Flow, to determine how well the company is positioned to perform in the future. Although Vaxart investors may analyze each financial statement separately, they are all interrelated. The changes in Vaxart's assets and liabilities, for example, are also reflected in the revenues and expenses on on Vaxart's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Free Cash Flow | -65.1 M | -61.8 M | |
| Free Cash Flow Yield | (1.00) | (0.95) | |
| Free Cash Flow Per Share | (0.45) | (0.47) | |
| EV To Free Cash Flow | (0.93) | (0.98) | |
| Price To Free Cash Flows Ratio | (1.03) | (1.08) | |
| Free Cash Flow Operating Cash Flow Ratio | 0.92 | 0.46 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vaxart Stock Analysis
When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.